ID   PRGR_RAT                Reviewed;         923 AA.
AC   Q63449;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 179.
DE   RecName: Full=Progesterone receptor;
DE            Short=PR;
DE   AltName: Full=Nuclear receptor subfamily 3 group C member 3;
GN   Name=Pgr; Synonyms=Nr3c3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Placenta;
RX   PubMed=8299566; DOI=10.1210/endo.134.2.8299566;
RA   Park-Sarge O.K., Mayo K.E.;
RT   "Regulation of the progesterone receptor gene by gonadotropins and cyclic
RT   adenosine 3',5'-monophosphate in rat granulosa cells.";
RL   Endocrinology 134:709-718(1994).
RN   [2]
RP   INDUCTION.
RX   PubMed=1840636; DOI=10.1210/mend-5-7-967;
RA   Park-Sarge O.K., Mayo K.E.;
RT   "Transient expression of progesterone receptor messenger RNA in ovarian
RT   granulosa cells after the preovulatory luteinizing hormone surge.";
RL   Mol. Endocrinol. 5:967-978(1991).
RN   [3]
RP   ALTERNATIVE PROMOTER USAGE.
RX   PubMed=8145766; DOI=10.1210/mend.7.12.8145766;
RA   Kraus W.L., Montano M.M., Katzenellenbogen B.S.;
RT   "Cloning of the rat progesterone receptor gene 5'-region and identification
RT   of two functionally distinct promoters.";
RL   Mol. Endocrinol. 7:1603-1616(1993).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=17003284; DOI=10.1677/joe.1.06923;
RA   Turgeon J.L., Waring D.W.;
RT   "Differential expression and regulation of progesterone receptor isoforms
RT   in rat and mouse pituitary cells and LbetaT2 gonadotropes.";
RL   J. Endocrinol. 190:837-846(2006).
CC   -!- FUNCTION: The steroid hormones and their receptors are involved in the
CC       regulation of eukaryotic gene expression and affect cellular
CC       proliferation and differentiation in target tissues. Depending on the
CC       isoform, progesterone receptor functions as a transcriptional activator
CC       or repressor (By similarity). {ECO:0000250|UniProtKB:P06401}.
CC   -!- FUNCTION: [Isoform A]: Ligand-dependent transdominant repressor of
CC       steroid hormone receptor transcriptional activity including repression
CC       of its isoform B, MR and ER. Transrepressional activity may involve
CC       recruitment of corepressor NCOR2. {ECO:0000250|UniProtKB:P06401}.
CC   -!- FUNCTION: [Isoform B]: Transcriptional activator of several
CC       progesteron-dependent promoters in a variety of cell types. Involved in
CC       activation of SRC-dependent MAPK signaling on hormone stimulation.
CC       {ECO:0000250|UniProtKB:P06401}.
CC   -!- SUBUNIT: Interacts with SMARD1 and UNC45A. Interacts with CUEDC2; the
CC       interaction promotes ubiquitination, decreases sumoylation, and
CC       represses transcriptional activity. Interacts with PIAS3; the
CC       interaction promotes sumoylation of PR in a hormone-dependent manner,
CC       inhibits DNA-binding, and alters nuclear export. Interacts with SP1;
CC       the interaction requires ligand-induced phosphorylation on Ser-344.
CC       Interacts with PRMT2 (By similarity). Isoform A interacts with NCOR2.
CC       Isoform B (but not isoform A) interacts with NCOA2 and NCOA1 (By
CC       similarity). Isoform B (but not isoform A) interacts with KLF9.
CC       Interacts with GTF2B (By similarity). {ECO:0000250|UniProtKB:P06401,
CC       ECO:0000250|UniProtKB:Q00175}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Nucleoplasmic shuttling
CC       is both hormone- and cell cycle-dependent. On hormone stimulation,
CC       retained in the cytoplasm in the G(1) and G(2)/M phases (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=B; Synonyms=PRB, PR-B;
CC         IsoId=Q63449-1; Sequence=Displayed;
CC       Name=A; Synonyms=PRA, PR-A;
CC         IsoId=Q63449-2; Sequence=VSP_058744;
CC   -!- TISSUE SPECIFICITY: Isoform A and isoform B are expressed in the
CC       pituitary. {ECO:0000269|PubMed:17003284}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- PTM: Phosphorylated on multiple serine sites. Several of these sites
CC       are hormone-dependent. Phosphorylation on Ser-293 is highly hormone-
CC       dependent and modulates ubiquitination and sumoylation on Lys-387.
CC       Phosphorylation on Ser-344 also requires induction by hormone. Basal
CC       phosphorylation on Ser-82, Ser-190 and Ser-399 is increased in response
CC       to progesterone and can be phosphorylated in vitro by the CDK2-A1
CC       complex. Increased levels of phosphorylation on Ser-399 also in the
CC       presence of EGF, heregulin, IGF, PMA and FBS. Phosphorylation at this
CC       site by CDK2 is ligand-independent, and increases nuclear translocation
CC       and transcriptional activity. Phosphorylation at Ser-293, but not at
CC       Ser-190, is impaired during the G(2)/M phase of the cell cycle.
CC       Phosphorylation on Ser-344 by ERK1/2 MAPK is required for interaction
CC       with SP1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Sumoylation is hormone-dependent and represses transcriptional
CC       activity. Sumoylation on all three sites is enhanced by PIAS3.
CC       Desumoylated by SENP1. Sumoylation on Lys-387, the main site of
CC       sumoylation, is repressed by ubiquitination on the same site, and
CC       modulated by phosphorylation at Ser-293 (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitination is hormone-dependent and represses sumoylation on
CC       the same site (By similarity). Promoted by MAPK-mediated
CC       phosphorylation on Ser-293 (By similarity). Ubiquitinated by UBR5,
CC       leading to its degradation: UBR5 specifically recognizes and binds
CC       ligand-bound PGR when it is not associated with coactivators (NCOAs)
CC       (By similarity). In presence of NCOAs, the UBR5-degron is not
CC       accessible, preventing its ubiquitination and degradation (By
CC       similarity). {ECO:0000250|UniProtKB:P06401}.
CC   -!- PTM: Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required
CC       for plasma membrane targeting and for rapid intracellular signaling via
CC       ERK and AKT kinases and cAMP generation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L16922; AAA19916.1; -; mRNA.
DR   PIR; I53280; I53280.
DR   RefSeq; NP_074038.1; NM_022847.1.
DR   AlphaFoldDB; Q63449; -.
DR   SMR; Q63449; -.
DR   STRING; 10116.ENSRNOP00000032053; -.
DR   BindingDB; Q63449; -.
DR   ChEMBL; CHEMBL2596; -.
DR   DrugCentral; Q63449; -.
DR   iPTMnet; Q63449; -.
DR   PhosphoSitePlus; Q63449; -.
DR   PaxDb; 10116-ENSRNOP00000032053; -.
DR   GeneID; 25154; -.
DR   KEGG; rno:25154; -.
DR   UCSC; RGD:3317; rat. [Q63449-1]
DR   AGR; RGD:3317; -.
DR   CTD; 5241; -.
DR   RGD; 3317; Pgr.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; Q63449; -.
DR   OrthoDB; 5347911at2759; -.
DR   PhylomeDB; Q63449; -.
DR   Reactome; R-RNO-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-RNO-4090294; SUMOylation of intracellular receptors.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   PRO; PR:Q63449; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0051117; F:ATPase binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0034056; F:estrogen response element binding; IBA:GO_Central.
DR   GO; GO:0042562; F:hormone binding; IMP:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; ISO:RGD.
DR   GO; GO:0003707; F:nuclear steroid receptor activity; IMP:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0005496; F:steroid binding; IMP:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071391; P:cellular response to estrogen stimulus; IEP:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEP:RGD.
DR   GO; GO:0071371; P:cellular response to gonadotropin stimulus; IEP:RGD.
DR   GO; GO:0071373; P:cellular response to luteinizing hormone stimulus; IEP:RGD.
DR   GO; GO:1904568; P:cellular response to wortmannin; IEP:RGD.
DR   GO; GO:0016101; P:diterpenoid metabolic process; IEP:RGD.
DR   GO; GO:0002070; P:epithelial cell maturation; ISO:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0060180; P:female mating behavior; IMP:RGD.
DR   GO; GO:0002071; P:glandular epithelial cell maturation; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:0001553; P:luteinization; IEP:RGD.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IEP:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:1904709; P:negative regulation of granulosa cell apoptotic process; IMP:RGD.
DR   GO; GO:0030518; P:nuclear receptor-mediated steroid hormone signaling pathway; IBA:GO_Central.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; ISO:RGD.
DR   GO; GO:0038001; P:paracrine signaling; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0050847; P:progesterone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0042220; P:response to cocaine; IDA:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0060748; P:tertiary branching involved in mammary gland duct morphogenesis; ISO:RGD.
DR   CDD; cd07172; NR_DBD_GR_PR; 1.
DR   CDD; cd07074; NR_LBD_PR; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050200; Nuclear_hormone_rcpt_NR3.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR000128; Progest_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR48092; KNIRPS-RELATED PROTEIN-RELATED; 1.
DR   PANTHER; PTHR48092:SF6; PROGESTERONE RECEPTOR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF02161; Prog_receptor; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00544; PROGESTRONER.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative promoter usage; Cytoplasm; DNA-binding; Isopeptide bond;
KW   Lipid-binding; Lipoprotein; Metal-binding; Nucleus; Palmitate;
KW   Phosphoprotein; Receptor; Reference proteome; Steroid-binding;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..923
FT                   /note="Progesterone receptor"
FT                   /id="PRO_0000053697"
FT   DOMAIN          669..903
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        557..629
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         557..577
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         593..617
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..556
FT                   /note="Modulating, Pro-Rich"
FT   REGION          1..164
FT                   /note="AF3; mediates transcriptional activation (in isoform
FT                   B)"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   REGION          1..49
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          67..111
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          152..239
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          165..304
FT                   /note="Mediates transcriptional transrepression (in isoform
FT                   A)"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   REGION          333..371
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          412..435
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          450..536
FT                   /note="AF1; mediates transcriptional activation"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   REGION          677..923
FT                   /note="AF2; mediates transcriptional activation"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOTIF           56..60
FT                   /note="LXXL motif 1"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOTIF           115..119
FT                   /note="LXXL motif 2"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOTIF           184..188
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        68..85
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        90..111
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        341..358
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        415..429
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         756
FT                   /ligand="progesterone"
FT                   /ligand_id="ChEBI:CHEBI:17026"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         190
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         293
FT                   /note="Phosphoserine; by MAPK1"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         344
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         399
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         666
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        387
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        387
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   CROSSLNK        521
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..164
FT                   /note="Missing (in isoform A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058744"
SQ   SEQUENCE   923 AA;  99408 MW;  05384B9656BF22DC CRC64;
     MTELQAKDPR TLHTSGAAPS PTHVGSPLLA RLDPDPFQGS QHSDASSVVS PIPISLDRLL
     FSRSCQAQEL PDEKTQNQQS LSDVEGAFSG VEASRRRSRN PRAPEKDSRL LDSVLDTLLA
     PSGPEQSQTS PPACEAITSW CLFGPELPED PRSVPATKGL LSPLMSRPES KAGDSSGTGA
     GQKVLPKAVS PPRQLLLPTS GSAHWPGAGV KPSQQPATVE VEEDGGLETE GSAGPLLKSK
     PRALEGMCSG GGVTANAPGA APGGVTLVPK EDSRFSAPRV SLEQDAPVAP GRSPLATTVV
     DFIHVPILPL NHALLAARTR QLLEGDSYDG GAAAQVPFAP PRGSPSAPSP PVPCGDFPDC
     TYPPEGDPKE DGFPVYGEFQ PPGLKIKEEE EGTEAASRSP RPYLLAGASA ATFPDFPLPP
     RPPRAPPSRP GEAAVAAPSA AVSPVSSSGS ALECILYKAE GAPPTQGSFA PLPCKPPAAS
     SCLLPRDSLP AAPTSSAAPA IYPPLGLNGL PQLGYQAAVL KDSLPQVYPP YLNYLRPDSE
     ASQSPQYGFD SLPQKICLIC GDEASGCHYG VLTCGSCKVF FKRAMEGQHN YLCAGRNDCI
     VDKIRRKNCP ACRLRKCCQA GMVLGGRKFK KFNKVRVMRA LDGVALPQSV AFPNESQTLG
     QRITFSPNQE IQLVPPLINL LMSIEPDVVY AGHDNTKPDT SSSLLTSLNQ LGERQLLSVV
     KWSKSLPGFR NLHIDDQITL IQYSWMSLMV FGLGWRSYKH VSGQMLYFAP DLILNEQRMK
     ELSFYSLCLT MWQIPQEFVK LQVTHEEFLC MKVLLLLNTI PLEGLRSQSQ FEEMRSSYIR
     ELIKAIGLRQ KGVVPSSQRF YQLTKLLDSL HDLVKQLHLY CLNTFIQSRA LAVEFPEMMS
     EVIAAQLPKI LAGMVKPLLF HKK
//
